A perspective on LILRBs and LAIR1 as immune checkpoint targets for cancer treatment
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Dec 01, 2022
- Source ID
- 10.1016/j.bbrc.2022.09.019
Entities
People
- Cheng Cheng Zhang
Organizations
- Cancer Prevention and Research Institute of Texas
- Leukemia & Lymphoma Society
- National Cancer Institute
- United States Department of Defense